Back to Market Feed

Historical record - last NADAC effective date: 10/19/2017

Product Information

NEUPOGEN 480 MCG/0.8 ML SYR is a brand product labeled by Amgen Inc., priced at $636.0120 per ML under NDC 55513020910. Its NADAC has been published 228 times since Nov 28, 2013.

NEUPOGEN 480 MCG/0.8 ML SYR

Filgrastim
$636.0120per ML

Strength

480 ug/.8mL

Manufacturer

Amgen Inc.

NDC

55513020910

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

10/19/2017

Active Ingredients

FILGRASTIM

Approval Type

Biologic (BLA)

FDA Application

BLA103353

On Market Since

10/2/2000

Pharmacological Classes

Granulocyte Colony-Stimulating Factor
Increased Myeloid Cell Production
Leukocyte Growth Factor

Price Statistics

The NADAC for NEUPOGEN 480 MCG/0.8 ML SYR has been published 228 times since Nov 28, 2013, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.

Current price$636.0120 per ML
All-time high$636.0120 (Oct 10, 2018)
All-time low$594.0918 (Nov 19, 2014)
Median price$612.0482
Average price$613.7327
Largest weekly change+2.9% (Oct 25, 2017)
Weeks tracked228
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+6.9%

Last surveyed Oct 10, 2018 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Filgrastim market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

NEULASTA 6 MG/0.6 ML SYRINGE
Brand
55513019001•Amgen Inc.
$10074.8571
per ML

Frequently asked questions

What is the NADAC price of NEUPOGEN 480 MCG/0.8 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for NEUPOGEN 480 MCG/0.8 ML SYR, manufactured by Amgen Inc., is $636.0120 per ML (NDC 55513020910), effective Oct 10, 2018.

How has the price of NEUPOGEN 480 MCG/0.8 ML SYR changed over time?

Over the history we have for it, the NADAC for NEUPOGEN 480 MCG/0.8 ML SYR has risen 6.9%. It has been tracked across 228 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEUPOGEN 480 MCG/0.8 ML SYR?

Since Nov 28, 2013, the NADAC for NEUPOGEN 480 MCG/0.8 ML SYR has ranged from a low of $594.0918 (Nov 19, 2014) to a high of $636.0120 (Oct 10, 2018), with a median of $612.0482 per ML.

Are there cheaper alternatives to NEUPOGEN 480 MCG/0.8 ML SYR?

No other NADAC-published product currently shares the active ingredient and strength of NEUPOGEN 480 MCG/0.8 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NEUPOGEN 480 MCG/0.8 ML SYR?

NEUPOGEN 480 MCG/0.8 ML SYR (NDC 55513020910) is labeled by Amgen Inc., and CMS classifies it as a brand product.